Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. On June 27, 2025, Kura Oncology, Inc. (the “ Company ”) and Kyowa Kirin, Inc. (“ Kyowa Kirin US ”) entered into a Co